PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
FBT vs. XBI
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between FBT and XBI is 0.89, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.


-0.50.00.51.00.9

Performance

FBT vs. XBI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in First Trust Amex Biotechnology Index (FBT) and SPDR S&P Biotech ETF (XBI). The values are adjusted to include any dividend payments, if applicable.

550.00%600.00%650.00%700.00%750.00%800.00%JulyAugustSeptemberOctoberNovemberDecember
758.69%
557.40%
FBT
XBI

Key characteristics

Sharpe Ratio

FBT:

0.61

XBI:

0.41

Sortino Ratio

FBT:

0.91

XBI:

0.74

Omega Ratio

FBT:

1.12

XBI:

1.09

Calmar Ratio

FBT:

0.46

XBI:

0.20

Martin Ratio

FBT:

2.16

XBI:

1.29

Ulcer Index

FBT:

4.81%

XBI:

8.18%

Daily Std Dev

FBT:

17.14%

XBI:

25.90%

Max Drawdown

FBT:

-40.51%

XBI:

-63.89%

Current Drawdown

FBT:

-8.59%

XBI:

-47.44%

Returns By Period

In the year-to-date period, FBT achieves a 5.45% return, which is significantly higher than XBI's 2.37% return. Over the past 10 years, FBT has outperformed XBI with an annualized return of 5.46%, while XBI has yielded a comparatively lower 4.32% annualized return.


FBT

YTD

5.45%

1M

1.05%

6M

9.20%

1Y

8.81%

5Y*

2.16%

10Y*

5.46%

XBI

YTD

2.37%

1M

-3.20%

6M

-1.05%

1Y

4.32%

5Y*

-1.28%

10Y*

4.32%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


FBT vs. XBI - Expense Ratio Comparison

FBT has a 0.57% expense ratio, which is higher than XBI's 0.35% expense ratio.


FBT
First Trust Amex Biotechnology Index
Expense ratio chart for FBT: current value at 0.57% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.57%
Expense ratio chart for XBI: current value at 0.35% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.35%

Risk-Adjusted Performance

FBT vs. XBI - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for First Trust Amex Biotechnology Index (FBT) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for FBT, currently valued at 0.61, compared to the broader market0.002.004.000.610.41
The chart of Sortino ratio for FBT, currently valued at 0.91, compared to the broader market-2.000.002.004.006.008.0010.000.910.74
The chart of Omega ratio for FBT, currently valued at 1.12, compared to the broader market0.501.001.502.002.503.001.121.09
The chart of Calmar ratio for FBT, currently valued at 0.46, compared to the broader market0.005.0010.0015.000.460.20
The chart of Martin ratio for FBT, currently valued at 2.16, compared to the broader market0.0020.0040.0060.0080.00100.002.161.29
FBT
XBI

The current FBT Sharpe Ratio is 0.61, which is higher than the XBI Sharpe Ratio of 0.41. The chart below compares the historical Sharpe Ratios of FBT and XBI, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.00JulyAugustSeptemberOctoberNovemberDecember
0.61
0.41
FBT
XBI

Dividends

FBT vs. XBI - Dividend Comparison

FBT's dividend yield for the trailing twelve months is around 0.71%, more than XBI's 0.14% yield.


TTM20232022202120202019201820172016201520142013
FBT
First Trust Amex Biotechnology Index
0.71%0.00%0.00%1.37%0.00%0.00%0.00%0.00%0.00%0.12%0.05%0.00%
XBI
SPDR S&P Biotech ETF
0.14%0.02%0.00%0.04%0.20%0.00%0.28%0.24%0.26%0.61%1.07%0.17%

Drawdowns

FBT vs. XBI - Drawdown Comparison

The maximum FBT drawdown since its inception was -40.51%, smaller than the maximum XBI drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for FBT and XBI. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-8.59%
-47.44%
FBT
XBI

Volatility

FBT vs. XBI - Volatility Comparison

The current volatility for First Trust Amex Biotechnology Index (FBT) is 5.93%, while SPDR S&P Biotech ETF (XBI) has a volatility of 7.92%. This indicates that FBT experiences smaller price fluctuations and is considered to be less risky than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


3.00%4.00%5.00%6.00%7.00%8.00%9.00%JulyAugustSeptemberOctoberNovemberDecember
5.93%
7.92%
FBT
XBI
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab